BRCA2 and breast carcinoma: A clear distinction between those two possibilities is crucial since treatments differ substantially and so does survival of the patient.<h4>Case presentation</h4>We present a case of a 47-year-old patient with bilateral breast carcinoma with a germline <i>BRCA2</i> pathogenic variant.